Price target
221.470.000.00%
The 27 analysts offering 1 year price forecasts for BIIB have a max estimate of — and a min estimate of —.
Analyst rating
Based on 36 analysts giving stock ratings to BIIB in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
BIIB EPS for the last quarter is 3.46 CHF despite the estimation of 3.20 CHF. In the next quarter EPS is expected to reach 3.05 CHF. Track more of BIOGEN IDEC financials and stay on top of what is up with the company.
In the next quarter BIOGEN IDEC revenue is expected to reach 2.13 B CHF. Check out BIOGEN IDEC revenue and earnings and make informed decisions.
According to analysts, BIIB price target is 221.47 CHF with a max estimate of 303.09 CHF and a min estimate of 159.52 CHF. Check if this forecast comes true in a year, meanwhile watch BIOGEN IDEC stock price chart and keep track of the current situation with BIIB news and stock market news.
We've gathered opinions of 36 analysts rating BIIB stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.